ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University

OSAKA, Japan, March 11, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University (Cambridge, MA, USA; "Harvard") aiming at validating novel therapeutic targets. In this alliance, as part of our ongoing open innovation initiative to collaborate...

Related Keywords

United States ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,Osaka ,Gyo Sagara ,Toichi Takino ,Isaac Kohlberg ,Harvard Gridand ,Harvard University Cambridge ,Harvard University ,Harvard University Office Of Technology Development ,Technology Development ,Prnewswire Ono Pharmaceutical Co Ltd ,Discovery Research At Ono ,Sustainability Translational Fund ,Harvard Office Of Technology Development ,Senior Executive Officer ,Executive Director ,Vivian Berlin ,Harvard Medical School ,Senior Associate Provost ,Chief Technology Development Officer ,Biomedical Accelerator ,Sustainability Translational ,